EFFECTS OF ANTIANDROGEN AND 5-ALPHA-REDUCTASE INHIBITOR ON PROSTATE TISSUE ANDROGEN CONTENT

被引：0
|
作者：
Shibata, Yasuhiro
Arai, Seiji
Nitta, Takashi
Miyazawa, Yoshiyuki
Kato, Haruo
Koike, Hidekazu
Ito, Kazuto
Suzuki, Kazuhiro
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.258
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP44-02
引用
收藏
页码：E598 / E598
页数：1
相关论文
共 50 条
  • [31] Suppressive effects of the antiandrogen agent, chlormadinone acetate and the 5α-reductase inhibitor, dutasteride on prostate weight and intraprostatic androgen levels in rats
    Kobayashi, Hideo
    Gotanda, Kotaro
    Shibata, Yasuhiro
    Watanabe, Jun-ichi
    Nakano, Youichi
    Shinbo, Atsushi
    Suzuki, Kazuhiro
    [J]. ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2011, 61 (09): : 515 - 520
  • [32] A COMPARISON OF THE EFFECTS OF CASTRATION AND 6-METHYLENE PROGESTERONE, A 5-ALPHA-REDUCTASE INHIBITOR, ON THE RAT VENTRAL PROSTATE
    MARTS, SA
    PADILLA, GM
    PETROW, V
    [J]. BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1987, 65 (07): : 626 - 634
  • [33] INVITRO AND INVIVO EFFECTS OF SURAMIN ON RAT PROSTATE TESTOSTERONE 5-ALPHA-REDUCTASE
    DISALLE, E
    ZACCHEO, T
    BRIATICO, G
    ORNATI, G
    [J]. EUROPEAN JOURNAL OF CANCER, 1990, 26 (02) : 184 - 184
  • [34] CLINICAL AND HORMONAL EFFECTS OF THE 5-ALPHA-REDUCTASE INHIBITOR FINASTERIDE IN IDIOPATHIC HIRSUTISM
    MOGHETTI, P
    CASTELLO, R
    MAGNANI, CM
    TOSI, F
    NEGRI, C
    ARMANINI, D
    BELLOTTI, G
    MUGGEO, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (04): : 1115 - 1121
  • [35] THE CLINICAL EFFECTS OF A 5-ALPHA-REDUCTASE INHIBITOR, FINASTERIDE, ON BENIGN PROSTATIC HYPERPLASIA
    STONER, E
    [J]. JOURNAL OF UROLOGY, 1992, 147 (05): : 1298 - 1302
  • [36] LABORATORY MONITORING OF ANDROGENIC ACTIVITY IN BENIGN PROSTATE HYPERTROPHY TREATED WITH A 5-ALPHA-REDUCTASE INHIBITOR
    MATZKIN, H
    CHAYEN, R
    GOLDFARB, H
    GILAD, S
    BRAF, Z
    [J]. CLINICAL CHEMISTRY, 1992, 38 (07) : 1304 - 1306
  • [37] Association of 5-alpha-reductase inhibitor and prostate cancer incidence and mortality: a meta-analysis
    Hu, Xu
    Wang, Yao-Hui
    Yang, Zhi-Qiang
    Shao, Yan-Xiang
    Yang, Wei-Xiao
    Li, Xiang
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (06) : 2519 - U15
  • [38] EVIDENCE FOR ATROPHY AND APOPTOSIS IN THE VENTRAL PROSTATE OF RATS GIVEN THE 5-ALPHA-REDUCTASE INHIBITOR FINASTERIDE
    RITTMASTER, RS
    MANNING, AP
    WRIGHT, AS
    THOMAS, LN
    WHITEFIELD, S
    NORMAN, RW
    LAZIER, CB
    ROWDEN, G
    [J]. ENDOCRINOLOGY, 1995, 136 (02) : 741 - 748
  • [39] REGIONAL DISTRIBUTION OF ANDROGEN RECEPTORS AND 5-ALPHA-REDUCTASE IN THE EQUINE EPIDIDYMIS
    GANJAM, VK
    GOFF, AL
    NONNEMAN, DJ
    WEST, DA
    SWEENEY, CL
    WILSON, DA
    DAWSON, L
    WELSHONS, WV
    [J]. JOURNAL OF REPRODUCTION AND FERTILITY, 1991, : 670 - 671
  • [40] 5-ALPHA-REDUCTASE INHIBITION AND PROSTATE-CANCER PREVENTION
    BRAWLEY, OW
    FORD, LG
    THOMPSON, I
    PERLMAN, JA
    KRAMER, BS
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1994, 3 (02) : 177 - 182
12345